High-Level Production and Purification of P30P2MSP119, an Important Vaccine Antigen for Malaria, Expressed in the Methylotropic Yeast Pichia pastoris

This publication has 21 references indexed in Scilit:

• Efficacy of Two Alternate Vaccines Based onPlasmodium falciparumMerozoite Surface Protein 1 in anAotusChallenge Trial
  Infection and Immunity, 2001
• Immunogenicity and Efficacy inAotusMonkeys of Four RecombinantPlasmodium falciparumVaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1
  Infection and Immunity, 2000
• Vaccine Efficacy of RecombinantPlasmodium falciparumMerozoite Surface Protein 1 in Malaria-Naive, -Exposed, and/or -RechallengedAotus vociferansMonkeys
  Infection and Immunity, 2000
• Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoid
  Vaccine, 1999
• Immunization against malaria with a recombinant protein
  Parasite Immunology, 1994
• Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1
  Molecular and Biochemical Parasitology, 1993
• Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1
  Molecular and Biochemical Parasitology, 1992
• A malaria merozoite surface protein (MSP1)-structure, processing and function
  Memórias do Instituto Oswaldo Cruz, 1992
• Proteolytic processing of thePlasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains
  Molecular and Biochemical Parasitology, 1991
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.
  The Journal of Experimental Medicine, 1990